As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/9/24  89bio, Inc.                       10-Q        3/31/24   53:6.5M                                   Donnelley … Solutions/FA 
  5/9/24  89bio, Inc.                       8-K:2,9      5/9/24   11:194K                                   Donnelley … Solutions/FA 
  5/3/24  Babler Martin                     4          Director²   1:5K   89bio, Inc.                       Donnelley … Solutions/FA 
 4/23/24  Babler Martin                     3          Director²   2:13K  89bio, Inc.                       Donnelley … Solutions/FA 
 4/19/24‡ 89bio, Inc.                       ARS        12/31/23    1:6.1M                                   Donnelley … Solutions/FA 
 4/17/24  89bio, Inc.                       DEFA14A                1:825K                                   Donnelley … Solutions/FA 
 4/17/24  89bio, Inc.                       DEF 14A     5/29/24    1:1M                                     Donnelley … Solutions/FA 
 4/17/24  89bio, Inc.                       8-K:5,7,9   4/13/24   11:167K                                   Donnelley … Solutions/FA 
 4/15/24  RA Capital Healthcare Fund LP     4          Dir.,%Own.² 1:16K  89bio, Inc.                       SEC Connect              
          Kolchinsky Peter
          Ra Capital Management, L.P.
          RA Capital Nexus Fund, L.P.
          Shah Rajeev M.
 4/10/24  89bio, Inc.                       8-K:1        4/4/24   10:140K                                   Donnelley … Solutions/FA 
  4/3/24  Palekar Rohan                     4          Dir.,Off.²  1:7K   89bio, Inc.                       Donnelley … Solutions/FA 
  4/1/24  Palekar Rohan                     144                    1:6K   89bio, Inc.                       Morgan Stanley … Svcs/FA 
  3/8/24‡ 89bio, Inc.                       S-8          3/8/24    4:68K                                    Donnelley … Solutions/FA 
  3/6/24‡ Ra Capital Management, L.P.       SC 13D/A               1:83K  89bio, Inc.                       Toppan Merrill/FA        
          Peter Kolchinsky³
          Ra Capital Healthcare Fund, L.P.³
          Rajeev Shah³
  3/6/24  RA Capital Healthcare Fund LP     4          Dir.,%Own.² 1:11K  89bio, Inc.                       SEC Connect              
          Kolchinsky Peter
          Ra Capital Management, L.P.
          RA Capital Nexus Fund, L.P.
          Shah Rajeev M.
  3/1/24  89bio, Inc.                       NT 10-K    12/31/23    1:31K                                    Donnelley … Solutions/FA 
  3/1/24  89bio, Inc.                       10-K       12/31/23   69:17M                                    Donnelley … Solutions/FA 
 2/29/24  89bio, Inc.                       8-K:2,9     2/29/24   11:200K                                   Donnelley … Solutions/FA 
 2/28/24  Palekar Rohan                     4          Dir.,Off.²  1:4K   89bio, Inc.                       Donnelley … Solutions/FA 
 2/26/24  Palekar Rohan                     144                    1:5K   89bio, Inc.                       Morgan Stanley … Svcs/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	NT 10-K	Notice of a Late Filing of a Form 10-K Annual Report — Form 12b-25.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.